THE NEXT GENERATION OF IMMUNOASSAYS

BLISA™

A proprietary bead-based platform enabling rapid, quantitative, and highly multiplexed immunoassays that empower scientists and organizations to make informed decisions with confidence.

Why BLISA™?

Rapid

Results in as little as 15 minutes.

Quantitative

Accurate, reproducible quantitative results.

Highly Multiplexed

Simultaneously detect dozens to hundreds of targets.

Low Sample Volume

As little as 20-50 uL of sample.

High Specificity

Engineered for exceptional sensitivity and specificity.

Automation Ready

Designed for high-throughput and seamless workflow.

Beyond BLISA™

Scientific & Technical Capabilities

Comprehensive expertise in assay development, multiplex immunoassays, biomarker analysis, automation, microfluidics, image analysis, and data science.

Scientific Collaboration & Custom Development

Partner with government agencies, academic laboratories, and industry to develop customized assays, validate new applications, and accelerate translation.

HelixShield™

Advanced molecular authentication and information protection technologies for secure digital and physical ecosystems.

Let’s advance
science together.

Partner with High Throughput Biology to develop innovative solutions that drive meaningful impact.